• Methicillin Sodium Salt: Precision Tools for MSSA Research W

  2026-06-30

  Methicillin sodium salt delivers exceptional specificity for MSSA infection models, enabling clear differentiation from MRSA and robust antibiotic susceptibility profiling. Leveraging APExBIO’s validated product, researchers can design reproducible, high-fidelity experiments targeting bacterial cell wall synthesis. Explore advanced workflows, troubleshooting strategies, and actionable protocol parameters for next-generation Staphylococcus aureus infection research.

• Spleen-Targeted Neoantigen mRNA Vaccine Drives Antitumor Imm

  2026-06-30

  Lin et al. introduce a spleen-targeted neoantigen mRNA vaccine that activates ISG15+ CD8+ T cells and induces tertiary lymphoid structure formation in hepatocellular carcinoma. This innovation links efficient spleen-selective mRNA delivery to robust, mechanistically defined antitumor immunity, with implications for next-generation cancer vaccine design.

• Z-DEVD-FMK in Melanoma and Neuroprotection: Beyond Caspase-3

  2026-06-29

  Explore how Z-DEVD-FMK, a potent caspase-3 inhibitor, enables advanced dissection of apoptosis and neuroprotection, with unique insights from cutting-edge melanoma research. This comprehensive review reveals new experimental horizons beyond standard apoptosis assays.

• Ionomycin Calcium Salt: Workflow Optimization for Calcium Si

  2026-06-29

  Ionomycin calcium salt delivers precision in modulating intracellular Ca2+ for apoptosis research and cancer cell inhibition. This guide unpacks robust protocols, troubleshooting tactics, and advanced applications harnessing APExBIO’s trusted calcium ionophore to streamline both fundamental and translational workflows.

• A Drug-Sensitized Yeast Platform for Sensitive mTOR Inhibito

  2026-06-28

  This study introduces a highly sensitive yeast-based system for identifying mTOR inhibitors, achieving over 200-fold improved detection compared to wild-type strains. The platform's ability to rigorously exclude non-mTOR-targeting compounds like Canagliflozin underpins its value for precise pathway-focused drug screening.

• Structure-Based Screening Identifies NSP15 Inhibitors for SA

  2026-06-27

  This article examines a structure-based virtual screening study that identified thymopentin and oleuropein as potent inhibitors of SARS-CoV-2 NSP15, a viral endoribonuclease involved in immune evasion. The findings highlight the value of computational methods in natural product-based antiviral drug discovery and provide a framework for future experimental validation.

• Quercetin Protects Cataract Lenses by Modulating Hippo Pathw

  2026-06-26

  This study demonstrates that quercetin alleviates cataract formation in vivo and in vitro by inactivating the Hippo signaling pathway, resulting in reduced oxidative stress and increased epithelial cell survival. These findings provide mechanistic evidence for Hippo pathway modulation as a promising target for non-surgical cataract intervention.

• Antipyrine in BBB Models: Applied Protocols and Optimization

  2026-06-26

  Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) is the reference standard for passive blood-brain barrier permeability assays, powering high-throughput CNS drug screening and robust pharmacokinetic studies. This article provides actionable workflows, key innovations from recent high-impact research, and troubleshooting guidance to maximize reproducibility and predictive accuracy.

• S63845: Selective MCL1 Inhibitor for Apoptosis Research

  2026-06-25

  S63845 is a highly selective small molecule MCL1 inhibitor that robustly induces BAX/BAK-dependent mitochondrial apoptosis in MCL1-dependent cancer cells. It demonstrates nanomolar affinity and strong in vivo efficacy with minimal off-target toxicity, making it a benchmark tool for hematological cancer research.

• CPI-613: Applied Workflows in Tumor Cell Metabolism Study

  2026-06-25

  CPI-613 (6,8-bis(benzylsulfanyl)octanoic acid) uniquely targets mitochondrial metabolism in cancer cells, enabling robust apoptosis and metabolic assays. This guide details experimental optimization, advanced applications, and troubleshooting strategies for researchers leveraging CPI-613 from APExBIO.

• Distinct Apoptotic Pathways in BMECs Induced by Candida krus

  2026-06-24

  This study elucidates how the yeast and hypha forms of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) through distinct signaling pathways. The findings clarify the molecular mechanisms of fungal mastitis and inform targeted research on MAPK and innate immune signaling in host-pathogen interactions.

• Mavorixafor in WHIM Syndrome: Mechanistic and Clinical Advan

  2026-06-23

  A phase 3 trial demonstrates that mavorixafor, a selective CXCR4 antagonist, significantly increases neutrophil and lymphocyte counts and reduces infection rates in WHIM syndrome patients. These results mark a substantial advance in targeted therapies for rare, multisystem immunodeficiencies.

• Catalpol Induces Osteoclast Apoptosis via Sirt6-ERα-FasL in

  2026-06-23

  This study uncovers a novel mechanism by which catalpol, a bioactive compound from Rehmannia glutinosa, mitigates postmenopausal osteoporosis in ovariectomized rats. By promoting osteoclast apoptosis through the Sirt6-ERα-FasL axis, catalpol demonstrates potential as a targeted intervention for estrogen deficiency-induced bone loss.

• Pronase E Protease Mixture: Optimizing Protein Sample Prep

  2026-06-22

  Pronase E’s broad-spectrum proteolytic activity delivers unmatched versatility for protein sample preparation, particularly in challenging contexts like ferroptosis pathway analysis in cancer research. This guide translates recent translational oncology advances into actionable protocols, troubleshooting advice, and workflow insights, positioning APExBIO’s Pronase E as a trusted research asset.

• JC-1 Mitochondrial Membrane Potential Assay Kit: Precision i

  2026-06-22

  Accelerate your mitochondrial research with the JC-1 Mitochondrial Membrane Potential Assay Kit, engineered for reproducibility and high-sensitivity ΔΨm detection. Explore how this APExBIO tool streamlines workflows in apoptosis, drug screening, and immunomodulation studies while providing actionable troubleshooting guidance.

453 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page